Fu S - Search Results

1

Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer.

Wang Z, Fu S, Zhao J, Zhao W, Shen Z, Wang D, Duan J, Bai H, Wan R, Yu J, Wang S, Chen H, Chen B, Wang L, Wang J. Wang Z, et al. Among authors: fu s. Cancer Lett. 2019 Jan;440-441:180-188. doi: 10.1016/j.canlet.2018.10.014. Epub 2018 Oct 19. Cancer Lett. 2019. PMID: 30347283

2

Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.

Wang Z, Shen Z, Li Z, Duan J, Fu S, Liu Z, Bai H, Zhang Z, Zhao J, Wang X, Wang J. Wang Z, et al. Among authors: fu s. Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9990-5. doi: 10.1073/pnas.1510837112. Epub 2015 Jul 27. Proc Natl Acad Sci U S A. 2015. PMID: 26216950 Free PMC article.

3

High-fidelity of non-small cell lung cancer xenograft models derived from bronchoscopy-guided biopsies.

Fu S, Zhao J, Bai H, Duan J, Wang Z, An T, Wang J. Fu S, et al. Thorac Cancer. 2016 Jan;7(1):100-10. doi: 10.1111/1759-7714.12291. Epub 2015 Sep 8. Thorac Cancer. 2016. PMID: 26813258 Free PMC article.

4

Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma.

Yu N, Fu S, Xu Z, Liu Y, Hao J, Zhang A, Wang B. Yu N, et al. Among authors: fu s. Int J Cancer. 2016 Jan 15;138(2):451-62. doi: 10.1002/ijc.29713. Epub 2015 Aug 18. Int J Cancer. 2016. PMID: 26239999

5

Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.

Wang J, Zhang Q, Zhu Q, Liu C, Nan X, Wang F, Fang L, Liu J, Xie C, Fu S, Song B. Wang J, et al. Among authors: fu s. J Cell Physiol. 2020 Feb;235(2):1296-1308. doi: 10.1002/jcp.29046. Epub 2019 Jul 5. J Cell Physiol. 2020. PMID: 31273792 Free PMC article.

6

Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study.

Nan X, Xie C, Zhu Q, Zhang J, Fu S, Han X, Zhang Q, Han B, Liu J. Nan X, et al. Among authors: fu s. Int J Clin Oncol. 2020 Aug;25(8):1492-1498. doi: 10.1007/s10147-020-01683-0. Epub 2020 May 24. Int J Clin Oncol. 2020. PMID: 32447474 Clinical Trial.

7

Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations.

Qin H, Ke J, Dong S, Li H, Zhu K, Fu S, Shao Q, Li Z. Qin H, et al. Among authors: fu s. BMC Cancer. 2022 Sep 24;22(1):1012. doi: 10.1186/s12885-022-10095-4. BMC Cancer. 2022. PMID: 36153486 Free PMC article.

8

miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.

Yu N, Fu S, Liu Y, Xu Z, Liu Y, Hao J, Wang B, Zhang A. Yu N, et al. Among authors: fu s. J Exp Clin Cancer Res. 2015 Sep 29;34:107. doi: 10.1186/s13046-015-0224-8. J Exp Clin Cancer Res. 2015. PMID: 26419932 Free PMC article.

9

Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy.

Wang Q, Tan X, Deng G, Fu S, Li J, Li Z. Wang Q, et al. Among authors: fu s. BMC Pulm Med. 2022 Mar 3;22(1):75. doi: 10.1186/s12890-022-01866-7. BMC Pulm Med. 2022. PMID: 35241046 Free PMC article.

10

Benign and malignant renal cells are differentially inhibited during prolonged organ preservation.

Yu N, Fu S, Liu Y, Fu Z, Meng J, Xu Z, Wang B, Zhang A. Yu N, et al. Among authors: fu s, fu z. PLoS One. 2013 Dec 9;8(12):e81745. doi: 10.1371/journal.pone.0081745. eCollection 2013. PLoS One. 2013. PMID: 24349123 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,245 results

Search Page

Filters